文献速递急性肾损伤慢性肾脏病肾移植

ANCA相关性血管炎患者肾脏功能的长期结局

Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

该研究纳入848例新诊断ANCA相关性血管炎(AAV)患者,来自7项随机对照试验(1995-2012),分析长期肾脏结局及危险因素,并比较三种组织学分类的预测性能。

要点

  • AAV患者5年和10年ESKD累积发生率分别为17%和22%。

核心结论

  • AAV早期诊断极为重要,即使较轻的肾脏受累也影响预后。
  • 需要肾脏替代治疗(KRT)的患者生存率最低,但符合条件的AAV患者肾移植结局良好。
  • 三种组织学评分系统均为肾脏结局的独立预后因素。

研究设计与样本

  • 数据集包括848例新诊断AAV患者,参与7项随机对照试验(1995-2012)。
  • 随访信息来自发送给原随机对照试验主要研究者的问卷。
  • 肾脏活检子队列包括214例有可用活检的患者。

主要发现

  • 5年和10年ESKD累积发生率分别为17%和22%。
  • 与匹配的一般人群相比,AAV伴肾脏受累患者即使处于慢性肾脏病早期阶段生存结局也较差。
  • 发生ESKD的患者主要死因为感染,其次为心血管疾病;未发生ESKD者的主要死因为恶性肿瘤。
  • 初始需要透析的患者中34%在治疗后肾功能恢复。

关键数值与推荐

  • 5年和10年ESKD累积发生率分别为17%和22%。
  • 初始需要透析的患者中34%肾功能恢复。
  • 肾脏风险评分预测肾脏生存的曲线下面积0.79(标准误0.03,95%置信区间0.71-0.83)。

临床怎么用

  • 对AAV患者应早期诊断并密切监测肾脏功能,即使轻度肾脏受累也需重视。
  • 发生ESKD的患者生存率低,需加强感染和心血管疾病管理。
  • 符合条件的AAV患者可考虑肾移植,结局良好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. METHODS: The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. RESULTS: The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years.In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). CONCLUSIONS: Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Sachez-Alamo B, Moi L, Bajema I, et al. Long-term outcome of kidney function in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2024. PMID: 38268409. doi:10.1093/ndt/gfae018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。